Guangzhou Baiyunshan Pharmaceutical Company Limited 

$1.6900
2
+$0.00+0%Monday 14:30

Statistics

Day High
2.14
Day Low
2.14
52W High
2.64
52W Low
1.69
Volume
300
Avg. Volume
0
Mkt Cap
2.75B
P/E Ratio
7.93
Dividend Yield
5.23%
Dividend
0.09

Upcoming

Dividends

5.23%Dividend Yield
Sep 2026
$0.04
Jul 2026
$0.07
Sep 2025
$0.06
Jul 2025
$0.06
Nov 2024
$0.06
10Y Growth
N/A
5Y Growth
5.52%
3Y Growth
1.9%
1Y Growth
-1.88%

Earnings

Oct 28Expected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q3 2026
0.04
0.08
0.12
0.16
Expected EPS
N/A
Actual EPS
0.03618999

Financials

3.83%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
10.79BRevenue
412.77MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GBPHCL), along with its various subsidiaries, operates as a comprehensive pharmaceutical enterprise. It is actively engaged in the research, development, production, and distribution of a wide array of products, including traditional Chinese patent medicines, Western pharmaceuticals, chemical raw materials, natural and biological medications, and chemical raw material intermediates. Its operations span both the People's Republic of China and international markets. The company structures its extensive operations into four primary segments: Great Southern TCM, Great Commerce, Great Health, and a miscellaneous 'Others' category. Beyond its core pharmaceutical manufacturing, GBPHCL's activities extend to the wholesale, retail, import, and export of both Western and traditional Chinese medicines, as well as medical apparatus and instruments. Furthermore, its diverse product portfolio encompasses the research, development, production, and sale of consumer health items such as beverages, various food products (including pre-packaged items and dairy), and a broad range of pharmaceutical formulations like tablets, capsules, lozenges, injections, and even traditional specialties like tortoise herb jelly. The group also strategically invests in the broader health industry, focusing on areas like medical care, health management, health preservation, and elderly care. Complementing these activities, it offers commercial and advertising services. As of December 31, 2021, GBPHCL maintained a substantial retail presence, operating 154 chain pharmacy outlets. This network comprised 22 Cai Zhi Lin pharmacies, 36 Jian Min pharmacies, 51 GPC Prescription Pharmacy locations, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd. outlets, alongside an additional 22 general retail stores. Tracing its origins back to its incorporation in 1997, the company was initially known as Guangzhou Pharmaceutical Company Limited. It adopted its current name, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, in August 2013. The company is headquartered in Guangzhou, China.
Show More
CEO
Yuan Cheng
Employees
27057
Country
China
ISIN
CNE100000387
WKN
000A0M4X5

Listings

0 Comments

Share your thoughts

FAQs

What is Guangzhou Baiyunshan Pharmaceutical Company Limited stock price today?▼
The current price of GZPHF is $1.69 USD — it has increased by +0% in the past 24 hours. Watch Guangzhou Baiyunshan Pharmaceutical Company Limited stock price performance more closely on the chart.
What is Guangzhou Baiyunshan Pharmaceutical Company Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Guangzhou Baiyunshan Pharmaceutical Company Limited stocks are traded under the ticker GZPHF.
What is Guangzhou Baiyunshan Pharmaceutical Company Limited market cap?▼
Today Guangzhou Baiyunshan Pharmaceutical Company Limited has the market capitalization of 2.75B
When is the next Guangzhou Baiyunshan Pharmaceutical Company Limited earnings date?▼
Guangzhou Baiyunshan Pharmaceutical Company Limited is going to release the next earnings report on March 12, 2027.
What were Guangzhou Baiyunshan Pharmaceutical Company Limited earnings last quarter?▼
GZPHF earnings for the last quarter are 0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Guangzhou Baiyunshan Pharmaceutical Company Limited revenue for the last year?▼
Guangzhou Baiyunshan Pharmaceutical Company Limited revenue for the last year amounts to 10.79B USD.
What is Guangzhou Baiyunshan Pharmaceutical Company Limited net income for the last year?▼
GZPHF net income for the last year is 412.77M USD.
Does Guangzhou Baiyunshan Pharmaceutical Company Limited pay dividends?▼
Yes, GZPHF dividends are paid semi-annual. The last dividend per share was 0.04 . As of today, Dividend Yield (FWD)% is 5.23%.
How many employees does Guangzhou Baiyunshan Pharmaceutical Company Limited have?▼
As of November 18, 2026, the company has 27,057 employees.
In which sector is Guangzhou Baiyunshan Pharmaceutical Company Limited located?▼
Guangzhou Baiyunshan Pharmaceutical Company Limited operates in the Health & Wellness sector.
When did Guangzhou Baiyunshan Pharmaceutical Company Limited complete a stock split?▼
Guangzhou Baiyunshan Pharmaceutical Company Limited has not had any recent stock splits.
Where is Guangzhou Baiyunshan Pharmaceutical Company Limited headquartered?▼
Guangzhou Baiyunshan Pharmaceutical Company Limited is headquartered in Guangzhou, China.